Bosentan AB 62.5 mg film-coat. tabl.

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Bosentan Monohydrate 64,541 mg - Eq. Bosentan 62,5 mg

Commercializzato da:

Aurobindo SA-NV

Codice ATC:

C02KX01

INN (Nome Internazionale):

Bosentan Monohydrate

Dosaggio:

62,5 mg

Forma farmaceutica:

Film-coated tablet

Composizione:

Bosentan Monohydrate 64.541 mg

Via di somministrazione:

Oral use

Area terapeutica:

Bosentan

Dettagli prodotto:

CTI code: 508142-07 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508151-02 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-08 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508151-01 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-05 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-06 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-09 - Pack size: 112 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-04 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508142-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 508151-03 - Pack size: 1000 - Commercialisation status: NO - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: No

Data dell'autorizzazione:

2017-03-28